Blockade of the CD93/IGFBP7 interaction by monoclonal antibodies thus promoted vascular maturation and reduced leakage, leading to reduced tumor hypoxia and increased tumor perfusion (Figure 3; Table 3). Here, IGFBP7 is linked to neoplasm.